Atlas Trials

Transthyretin Amyloidosis Polyneuropathy

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Transthyretin Amyloidosis Polyneuropathy

RecordFirmDate
A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) (NCT06539208)YolTech Therapeutics Co., Ltd2024-05-23

Track Transthyretin Amyloidosis Polyneuropathy automatically

Every clearance here is in the API, with alerts when new ones post.